Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

To navigate sanctions in Venezuela, investors avoid buying local companies directly. The standard practice is to create a new US legal entity, execute an asset purchase from the local business, and transfer those assets into the US holding structure, minimizing legal and reputational risk.

Related Insights

Before any significant capital flows into Venezuela's oil sector, the near future will be dedicated to political negotiation and establishing a stable legal framework. Major players like Exxon still consider the country "uninvestable," meaning the primary focus will be on creating the conditions for future investment, not the investment itself.

A significant operational challenge in Venezuela's PE market is the low financial sophistication of sellers. Many owners use arbitrary math for valuations (e.g., '3 shareholders who each want $10M'), requiring extensive investor handholding and causing many transactions to fail.

Sanctions on major Russian oil companies don't halt exports but instead push them into opaque channels. Russia uses independent traders and restructured ownership to create "unknown" cargos, removing sanctioned company names from documents. This model, proven with smaller firms, maintains export volumes while obscuring the oil's origin.

A board member's role includes flagging strategic risks, including geopolitical exposure that could drastically limit future acquirers or prevent an IPO. Advising a CEO to relocate teams from a high-risk country is not operational meddling, but a core governance duty.

While innovation from China is increasingly integrated into Western pharma pipelines, there's little expectation of outright acquisitions of Chinese companies. The consensus is that licensing a specific asset is far simpler and avoids the significant political and regulatory complexities of a full M&A transaction.

Contrary to assumptions, oil majors are cautious about re-entering Venezuela. They worry about a lack of legal certainty and the risk that any deals could be undone and heavily scrutinized by a future U.S. administration, making the investment too risky.

To capitalize on promising Chinese biotech assets while mitigating risks in IP and manufacturing (CMC), investors are creating new US-based companies ("NewCos"). This structure allows an experienced US leadership team and board to guide the asset's development to meet global regulatory standards.

The country is "uninvestable" not just due to political risk, but because of its legal structure. Current law requires foreign firms to partner with the national oil company, giving it a 51% stake. As this state entity is bankrupt and in default, any revenue it receives would be immediately frozen by creditors, making partnerships non-viable.

The hosts argue that even with vast oil reserves and government encouragement, the political instability, power vacuum, and lack of rule of law in Venezuela make it a poor investment for oil companies. The cost and uncertainty of securing profits are too high.

China uses small, independent "teapot" refineries to buy sanctioned oil from nations like Iran. These entities are more risk-tolerant than state-owned giants because they have little exposure to the U.S. dollar system. This parallel structure allows China to secure cheap energy while its major firms avoid direct sanctions risk.